Hp. Ciolino et al., EFFECT OF CURCUMIN ON THE ARYL-HYDROCARBON RECEPTOR AND CYTOCHROME-P450 1A1 IN MCF-7 HUMAN BREAST-CARCINOMA CELLS, Biochemical pharmacology, 56(2), 1998, pp. 197-206
We examined the interaction of curcumin,a dietary constituent and chem
opreventive compound, with the carcinogen activation pathway mediated
by the aryl hydrocarbon receptor (AhR) in MCF-7 mammary epithelial car
cinoma cells. Curcumin caused a rapid accumulation.of cytochrome P450
1A1 (CYP1A1) mRNA in a time- and concentration-dependent manner, and C
YP1A1 monooxygenase activity increased as measured by ethoxyresorufin-
O-deethylation. Curcumin activated the DNA-binding capacity of the AhR
for the xenobiotic responsive element of CYP1A1 as measured by the el
ectrophoretic-mobility shift assay (EMSA). Curcumin was able to compet
e with the prototypical AhR ligand 2,3,7,8-tetrachlorodibenzo-p-dioxin
for binding to the AhR in isolated MCF-7 cytosol, indicating that it
interacts directly with the receptor. Although curcumin could activate
the AhR on its own, it partially inhibited the activation of AhR, as
measured by EMSA, and partially decreased the accumulation of CYP1A1 m
RNA caused by the mammary carcinogen dimethylbenzanthracene (DMBA). Cu
rcumin competitively inhibited CYP1A1 activity in DMBA-treated cells a
nd in microsomes isolated from DMBA-treated cells. Curcumin also inhib
ited the metabolic activation of DMBA, as measured by the formation of
DMBA-DNA adducts, and decreased DMBA-induced cytotoxicity. These resu
lts suggest that the chemopreventive effect of curcumin may be due, in
part, to its ability to compete with aryl hydrocarbons for both the A
hR and CYP1A1. Curcumin may thus be a natural ligand and substrate of
the AhR pathway. (C) 1998 Elsevier Science Inc.